ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 162 filers reported holding ANTARES PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $179,000 | -27.8% | 43,856 | -36.8% | 0.00% | – |
| Q4 2021 | $248,000 | +56.0% | 69,446 | +59.5% | 0.00% | – |
| Q3 2021 | $159,000 | -10.7% | 43,533 | +6.8% | 0.00% | – |
| Q2 2021 | $178,000 | +7.2% | 40,779 | +0.7% | 0.00% | – |
| Q1 2021 | $166,000 | +11.4% | 40,513 | +8.6% | 0.00% | – |
| Q4 2020 | $149,000 | +65.6% | 37,303 | +11.0% | 0.00% | – |
| Q3 2020 | $90,000 | +125.0% | 33,600 | +133.1% | 0.00% | – |
| Q2 2020 | $40,000 | -54.5% | 14,413 | -61.3% | 0.00% | – |
| Q1 2020 | $88,000 | +44.3% | 37,250 | +185.5% | 0.00% | – |
| Q4 2019 | $61,000 | +29.8% | 13,049 | -8.4% | 0.00% | – |
| Q3 2019 | $47,000 | 0.0% | 14,250 | 0.0% | 0.00% | – |
| Q2 2019 | $47,000 | -2.1% | 14,250 | -9.5% | 0.00% | – |
| Q1 2019 | $48,000 | +11.6% | 15,750 | 0.0% | 0.00% | – |
| Q4 2018 | $43,000 | -34.8% | 15,750 | -20.6% | 0.00% | – |
| Q3 2018 | $66,000 | +83.3% | 19,826 | +42.8% | 0.00% | – |
| Q2 2018 | $36,000 | +20.0% | 13,882 | +0.6% | 0.00% | – |
| Q1 2018 | $30,000 | -9.1% | 13,796 | -16.8% | 0.00% | – |
| Q4 2017 | $33,000 | -54.8% | 16,572 | -26.1% | 0.00% | – |
| Q3 2017 | $73,000 | +128.1% | 22,424 | +130.0% | 0.00% | – |
| Q2 2017 | $32,000 | +14.3% | 9,750 | -0.4% | 0.00% | – |
| Q1 2017 | $28,000 | +21.7% | 9,788 | +0.4% | 0.00% | – |
| Q4 2016 | $23,000 | +43.8% | 9,750 | -0.4% | 0.00% | – |
| Q3 2016 | $16,000 | +60.0% | 9,794 | -5.4% | 0.00% | – |
| Q2 2016 | $10,000 | +11.1% | 10,350 | 0.0% | 0.00% | – |
| Q1 2016 | $9,000 | -75.0% | 10,350 | -66.0% | 0.00% | – |
| Q4 2015 | $36,000 | +24.1% | 30,423 | +73.6% | 0.00% | – |
| Q3 2015 | $29,000 | -25.6% | 17,520 | -4.8% | 0.00% | – |
| Q2 2015 | $39,000 | +62.5% | 18,394 | +107.8% | 0.00% | – |
| Q1 2015 | $24,000 | +4.3% | 8,850 | 0.0% | 0.00% | – |
| Q4 2014 | $23,000 | +53.3% | 8,850 | +12.7% | 0.00% | – |
| Q3 2014 | $15,000 | +36.4% | 7,850 | +84.7% | 0.00% | – |
| Q2 2014 | $11,000 | -26.7% | 4,250 | 0.0% | 0.00% | – |
| Q1 2014 | $15,000 | -34.8% | 4,250 | -19.0% | 0.00% | – |
| Q4 2013 | $23,000 | -32.4% | 5,250 | -38.4% | 0.00% | – |
| Q3 2013 | $34,000 | +54.5% | 8,527 | +62.4% | 0.00% | – |
| Q2 2013 | $22,000 | – | 5,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |